Carregant...
Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer
Triple Negative Breast Cancer (TNBC) continues to present a challenge in the clinic, as there is still no approved targeted therapy. TNBC is the worst sub-type of breast cancer in terms of prognosis and exhibits a deficiency in estrogen, progesterone, and human epidermal growth factor 2 (HER2) recep...
Guardat en:
| Publicat a: | Oncomedicine |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5292187/ https://ncbi.nlm.nih.gov/pubmed/28174679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/oncm.17406 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|